6 matches for your search in the start-up spotlight
rss
To detect hereditary diseases and genetic defects, physicians as well as researchers need appropriate tools. It is also essential to have the appropriate tools to support law enforcement agencies in resolving crimes and facilitating other legal issues, like kinship and paternity cases. Overtime ...
Elypta is developing the first-ever metabolism-based liquid biopsy platform for early detection and closer follow-up of multiple cancer indications. The platform is inherently safe and convenient, exceptionally sensitive in studies to date and the low cost assay technology allows for broad use. ...
Ending Antibiotic Misuse. Clemedi is a paradigm shift Clemedi provides complete information to clinicians when most needed: early. It renderscomprehensive information more quickly leading to faster, targeted therapy thus creating value. It will massively reduce the USD 11 digit direct and ...
